Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Morgan, R, O'Callaghan, J, Knight, SR, Morris, P
Formato:	Journal article
Idioma:	English
Publicado em:	2012

Registros relacionados

Systematic reviews of alemtuzumab in renal transplantation.
por: O'Callaghan, J, et al.
Publicado em: (2013)

Systematic reviews of alemtuzumab in renal transplantation
por: O'Callaghan, J, et al.
Publicado em: (2013)

Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
por: O'Callaghan, J, et al.
Publicado em: (2013)

Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
por: O'Callaghan, J, et al.
Publicado em: (2012)

Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
por: O'Callaghan, J, et al.
Publicado em: (2012)

ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION
por: Muthusamy, A, et al.
Publicado em: (2011)

Systematic review of clinical practice guidelines in kidney transplantation
por: O'Donoghue, K, et al.
Publicado em: (2017)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
por: Watson, C, et al.
Publicado em: (2005)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
por: Haynes, R, et al.
Publicado em: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
por: Haynes, R, et al.
Publicado em: (2014)

Alemtuzumab induction and steroid free immunosupprssion in pancreas transplantation.
por: Muthusamy, A, et al.
Publicado em: (2007)

Critical appraisal of United Kingdom clinical practice guidelines in kidney transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: A systematic review
por: Knight, S, et al.
Publicado em: (2017)

The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis.
por: OʼCallaghan, J, et al.
Publicado em: (2014)

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
por: Muthusamy, A, et al.
Publicado em: (2008)

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction
por: Muthusamy, A, et al.
Publicado em: (2007)

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation
por: A. Benazzo, et al.
Publicado em: (2022-04-01)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Martina Guthoff, et al.
Publicado em: (2020-05-01)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
por: Flechner, S, et al.
Publicado em: (2005)

Terapia de indução com alentuzumabe em receptores de transplante renal Alemtuzumab induction in kidney transplant recipients
por: Edison Luiz Mandia Sampaio, et al.
Publicado em: (2010-03-01)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
por: Haynes, R, et al.
Publicado em: (2014)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
por: Lukas K. van Vugt, et al.
Publicado em: (2023-11-01)

Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
por: A Khalafi-Nezhad, et al.
Publicado em: (2015-10-01)

A national registry analysis of kidney allografts preserved with Marshall's Solution in the United Kingdom
por: O'Callaghan, J, et al.
Publicado em: (2015)

Kidney transplantation--the long term view.
por: O'Callaghan, C
Publicado em: (2008)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
por: Plata-Munoz, J, et al.
Publicado em: (2009)

Evidence based hypothermic preservation of the kidney and liver for transplantation
por: O'Callaghan, JM
Publicado em: (2014)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Masashi Furukawa, et al.
Publicado em: (2022-06-01)

The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis
por: Marco Puthenparampil, et al.
Publicado em: (2025-01-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
por: Adil S. Lakha, et al.
Publicado em: (2024-08-01)

Low incidence of lymphoproliferative disease post kidney transplantation with prevalent use of alemtuzumab
por: John Fredy Nieto-Ríos, et al.
Publicado em: (2014-01-01)

Transplant Trial Watch
por: John Matthew O’Callaghan, et al.
Publicado em: (2023-09-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
por: Lakha, AS, et al.
Publicado em: (2024)

Critical appraisal of International Clinical Practice Guidelines in Kidney Transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: a systematic review
por: O'Donoghue, K, et al.
Publicado em: (2018)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
por: Naoki Okada, et al.
Publicado em: (2023-08-01)

Transplant Trial Watch
por: John M. O’Callaghan, et al.
Publicado em: (2025-01-01)

Transplant Trial Watch
por: John M. O’Callaghan, et al.
Publicado em: (2024-07-01)

Transplant Trial Watch
por: John M. O’Callaghan, et al.
Publicado em: (2024-09-01)

Transplant Trial Watch
por: Simon R. Knight, et al.
Publicado em: (2024-10-01)

Transplant Trial Watch
por: Simon R. Knight, et al.
Publicado em: (2024-02-01)

Transplant Trial Watch
por: John M. O’Callaghan, et al.
Publicado em: (2024-01-01)